MY136029A - Pharmaceutical compounds - Google Patents
Pharmaceutical compoundsInfo
- Publication number
- MY136029A MY136029A MYPI20005670A MYPI20005670A MY136029A MY 136029 A MY136029 A MY 136029A MY PI20005670 A MYPI20005670 A MY PI20005670A MY PI20005670 A MYPI20005670 A MY PI20005670A MY 136029 A MY136029 A MY 136029A
- Authority
- MY
- Malaysia
- Prior art keywords
- alkyl
- hydrogen
- unsubstituted
- substituted
- different
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
- C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
- C07D241/46—Phenazines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9928542.1A GB9928542D0 (en) | 1999-12-02 | 1999-12-02 | Pharmaceutical compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MY136029A true MY136029A (en) | 2008-07-31 |
Family
ID=10865607
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MYPI20005670A MY136029A (en) | 1999-12-02 | 2000-12-01 | Pharmaceutical compounds |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP1240148A1 (fr) |
| JP (1) | JP2003518103A (fr) |
| KR (1) | KR100767613B1 (fr) |
| CN (1) | CN1304380C (fr) |
| AU (1) | AU784397B2 (fr) |
| BR (1) | BR0016093A (fr) |
| CA (1) | CA2392873A1 (fr) |
| GB (2) | GB9928542D0 (fr) |
| HK (1) | HK1046133B (fr) |
| HU (1) | HUP0300392A3 (fr) |
| MX (1) | MXPA02005476A (fr) |
| MY (1) | MY136029A (fr) |
| PL (1) | PL356482A1 (fr) |
| TW (1) | TWI280242B (fr) |
| WO (1) | WO2001046157A1 (fr) |
| ZA (1) | ZA200204296B (fr) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2433071A (en) * | 2005-12-05 | 2007-06-13 | Kontrakt Technology Ltd | Organic acids comprising planar conjugated heterocyclic molecular system, & photoelectric layer thereof with rodlike supramolecules for use in solar cell |
| CN102898388B (zh) * | 2012-09-26 | 2014-12-03 | 浙江工业大学 | 一种合成取代苯并[α]吩嗪类化合物的方法 |
| CN103360329B (zh) * | 2013-07-18 | 2015-11-18 | 中国科学院南海海洋研究所 | 一类吩嗪化合物及其在制备抗肿瘤药物中的应用 |
| CN106554321B (zh) * | 2015-09-25 | 2019-05-28 | 陆源 | 一种吩嗪类物质、其制备方法及其应用 |
| CN113461623A (zh) * | 2021-07-14 | 2021-10-01 | 长江大学 | 一种抗病毒化合物及其制备方法和应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE195869T1 (de) * | 1992-05-28 | 2000-09-15 | Xenova Ltd | Acridin carboxamide zur behandlung von krebs |
| US5696131A (en) * | 1993-01-22 | 1997-12-09 | Xenova Limited | Treatment of cancers |
| TR199900636T2 (xx) * | 1996-09-23 | 1999-10-21 | Rutgers, The State University Of New Jersey | Anti-t�m�r ajanlar� olarak ikameli/katk�l� heterosayk�llar. |
| WO1998045272A1 (fr) * | 1997-04-07 | 1998-10-15 | Latrobe University | Inhibiteurs de la topoisomerase |
-
1999
- 1999-12-02 GB GBGB9928542.1A patent/GB9928542D0/en not_active Ceased
-
2000
- 2000-12-01 WO PCT/GB2000/004609 patent/WO2001046157A1/fr active Application Filing
- 2000-12-01 HU HU0300392A patent/HUP0300392A3/hu unknown
- 2000-12-01 EP EP00979799A patent/EP1240148A1/fr not_active Withdrawn
- 2000-12-01 CN CNB008187096A patent/CN1304380C/zh not_active Expired - Fee Related
- 2000-12-01 MY MYPI20005670A patent/MY136029A/en unknown
- 2000-12-01 KR KR1020027007033A patent/KR100767613B1/ko not_active IP Right Cessation
- 2000-12-01 AU AU17184/01A patent/AU784397B2/en not_active Ceased
- 2000-12-01 CA CA002392873A patent/CA2392873A1/fr not_active Abandoned
- 2000-12-01 GB GB0215275A patent/GB2373499B/en not_active Expired - Fee Related
- 2000-12-01 JP JP2001547068A patent/JP2003518103A/ja active Pending
- 2000-12-01 MX MXPA02005476A patent/MXPA02005476A/es not_active Application Discontinuation
- 2000-12-01 BR BR0016093-8A patent/BR0016093A/pt not_active IP Right Cessation
- 2000-12-01 PL PL00356482A patent/PL356482A1/xx not_active Application Discontinuation
- 2000-12-02 TW TW089125715A patent/TWI280242B/zh not_active IP Right Cessation
-
2002
- 2002-05-29 ZA ZA200204296A patent/ZA200204296B/en unknown
- 2002-10-10 HK HK02107392.7A patent/HK1046133B/zh not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| GB2373499A (en) | 2002-09-25 |
| GB2373499B (en) | 2004-11-17 |
| KR20020070305A (ko) | 2002-09-05 |
| HUP0300392A2 (hu) | 2003-07-28 |
| BR0016093A (pt) | 2002-08-20 |
| CA2392873A1 (fr) | 2001-06-28 |
| TWI280242B (en) | 2007-05-01 |
| HK1046133B (zh) | 2005-04-15 |
| CN1433406A (zh) | 2003-07-30 |
| CN1304380C (zh) | 2007-03-14 |
| KR100767613B1 (ko) | 2007-10-19 |
| JP2003518103A (ja) | 2003-06-03 |
| AU1718401A (en) | 2001-07-03 |
| GB9928542D0 (en) | 2000-02-02 |
| HK1046133A1 (en) | 2002-12-27 |
| GB0215275D0 (en) | 2002-08-14 |
| EP1240148A1 (fr) | 2002-09-18 |
| ZA200204296B (en) | 2003-05-29 |
| MXPA02005476A (es) | 2003-09-22 |
| WO2001046157A1 (fr) | 2001-06-28 |
| HUP0300392A3 (en) | 2003-09-29 |
| AU784397B2 (en) | 2006-03-23 |
| PL356482A1 (en) | 2004-06-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EG20396A (en) | Process for preparing of 5-aryundole derivatives | |
| EA200200078A1 (ru) | Птеридиноны в качестве ингибиторов киназ | |
| MY126139A (en) | Piperidine compounds for use as ccr-3 inhibitors | |
| NZ332960A (en) | tetrahydro-cyclopropan[c]benz[e]-indol-4-one and tetrahydro-cyclopropan[c]benzo[e]-indole derivatives and medicaments | |
| NZ513393A (en) | Camptothecin derivatives having antitumor activity | |
| WO1998050357A3 (fr) | Indole-3-carbinol, diindolylmethane et analogues substitues utilises comme anti-oestrogenes | |
| IL117875A0 (en) | Pharmaceutical compositions for inhibiting th growth of cancers | |
| ES395714A1 (es) | Procedimiento para la obtencion de derivados de piridoqui- nolina. | |
| SE8505715L (sv) | Indolderivat | |
| MY136029A (en) | Pharmaceutical compounds | |
| MY131762A (en) | Pharmaceutical compounds | |
| CO5080785A1 (es) | Derivados heterociclicos | |
| ATE247660T1 (de) | Furopyridinderivate und ihre therapeutische verwendung | |
| ES417638A1 (es) | Procedimiento para preparar oxazoles 2,4,5-trisustituidos. | |
| ES308210A1 (es) | Procedimiento para la obtencion de compuestos piridinicos. | |
| MX9706014A (es) | Derivados de xanteno y acridina y su empleo. | |
| MY141374A (en) | Water soluble camptothecin derivatives | |
| FR2479219B1 (fr) | ||
| ES2055651A1 (es) | Procedimiento para la obtencion de nuevas amidinas derivadas de 3-aminoetilindoles. | |
| ES8101071A1 (es) | Procedimiento para preparar nuevos derivados de (piridil-2)-2-tetrahidrotiofeno | |
| ES395762A1 (es) | Un procedimiento para la preparacion de derivados de benzo-diacepina. | |
| ES8505653A1 (es) | Procedimiento para preparar un n-alquil-(3 o 4)piperidinil benzoato | |
| ES306767A1 (es) | Procedimiento para la preparacion de nuevos derivados basicos de tiepina y oxepina. | |
| FI922694A0 (fi) | Tioxantenonderivat med antitumoer- effekt. | |
| NZ335975A (en) | Heterocyclic substituted pyrrolidine amide derivatives useful in treating respiratory diseases |